Published Online
on August 28, 2008

A more recent version of this article appeared on January 1, 2009

This Article Full Text (PDF) All Versions of this Article: 40/1/5    most recent STROKEAHA.108.527903v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gattellari, M. Articles by Zwar, N. Search for Related Content PubMed PubMed Citation Articles by Gattellari, M. Articles by Zwar, N. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Blood Thinners Stroke Hazardous Substances DB WARFARIN Related Collections Acute Cerebral Infarction Anticoagulants Related Article

Warfarin. An Inconvenient Truth

Melina Gattellari PhD; John Worthington MBBS^*; and Nicholas Zwar PhD

From School of Public Health and Community Medicine (M.G., N.Z.), The University of New South Wales, Australia; the Centre for Research, Evidence Management and Surveillance (M.G.), Division of Population Health, Sydney South West Area Health Service, NSW, Australia; The Northern Beaches Stroke Service (J.W.), Sydney, NSW, Australia; Sydney South West Clinical School, The University of New South Wales and Liverpool Health Service, Liverpool, NSW, Australia.

^* To whom correspondence should be addressed. E-mail: John.Worthington{at}sswahs.nsw.gov.au.

Key words: atrial fibrillation • evidence–practice gaps • warfarin

Related Article:

Potentially Preventable Strokes in High-Risk Patients With Atrial Fibrillation Who Are Not Adequately Anticoagulated

David J. Gladstone, Esther Bui, Jiming Fang, Andreas Laupacis, M. Patrice Lindsay, Jack V. Tu, Frank L. Silver, and Moira K. Kapral
Stroke 2009 40: 235-240. [Abstract] [Full Text] [PDF]